Integrated DNA Technologies Acquires ArcherDX Next Generation Sequencing Research Assays from Invitae CorporationBusiness Wire • 12/20/22
Invitae Completes Selected Assets Sale of its Next Generation Sequencing (NGS) research assays to Integrated DNA Technologies, Inc.PRNewsWire • 12/20/22
Invitae Executive Appointed to National Health Information Technology Advisory CommitteePRNewsWire • 12/19/22
Invitae Releases Data Use Transparency Report, Demonstrating the Impact of Patient Data on Genetic ResearchPRNewsWire • 12/07/22
Invitae Launches Rare Patient Network for Pediatric Patients With Rare Neurodevelopmental DiseasesPRNewsWire • 12/01/22
Wavemaker Three-Sixty Health Celebrates Investment Milestone at HLTH 2022: 50 Companies in 50 Months; Portfolio Exceeds $2.5BB in ValuationBusiness Wire • 11/14/22
Invitae Showcases Advances in Medical Genomics at the National Society of Genetic Counselors (NSGC) 41st Annual ConferencePRNewsWire • 11/10/22
Invitae study shows therapy informed by genetic testing reduces seizures in some patients with epilepsyPRNewsWire • 10/31/22
Invitae to Present Data at the American Society of Human Genetics Annual Meeting Furthering the Understanding of Variants of Uncertain Significance in Underrepresented PopulationsPRNewsWire • 10/28/22
Invitae Announces Partnership for Real-World Data Sharing to Inform Rare Cancer ResearchPRNewsWire • 10/27/22